Company Filing History:
Years Active: 2013-2016
Title: Innovations in Cancer Treatment by Luis Filipe Ferreira Neves
Introduction
Luis Filipe Ferreira Neves is a prominent inventor based in Norman, OK (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 2 patents, Neves is dedicated to advancing medical science and improving patient outcomes.
Latest Patents
Neves' latest patents focus on compositions and methods for cancer treatment using targeted carbon nanotubes. One of his inventions discloses compositions for detecting and/or destroying cancer tumors and/or cancer cells via photodynamic therapy. These compositions comprise a linking protein or peptide attached to a carbon nanotube, forming a targeted protein-carbon nanotube complex. Another patent presents a method for detecting and destroying cancer tumors by associating a linking protein, such as annexin V, with carbon nanotubes. This method allows for selective binding to cancerous cells, particularly tumor vasculature endothelial cells, while sparing healthy cells. The irradiation of bound carbon nanotubes with specific electromagnetic wavelengths is then employed to detect and eliminate the targeted cancer cells.
Career Highlights
Neves is affiliated with the University of Oklahoma, where he conducts his research and develops his innovative technologies. His work has garnered attention for its potential to revolutionize cancer treatment and improve therapeutic strategies.
Collaborations
Neves collaborates with esteemed colleagues, including Roger G Harrison, Jr. and Daniel E Resasco. Their combined expertise enhances the research and development of effective cancer treatment methodologies.
Conclusion
Luis Filipe Ferreira Neves is a dedicated inventor whose work in cancer treatment using targeted carbon nanotubes showcases his commitment to advancing medical science. His innovative patents reflect a significant step forward in the fight against cancer, promising improved detection and treatment options for patients.